Arca
Skip to content
Tools
Tools

Trigeminal neuralgia

Drug research and approvals for trigeminal neuralgia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 23 studies of trigeminal neuralgia are recruiting on ClinicalTrials.gov, Health Canada has authorized 1 drug trials for it since 2013, and FDA has 0 approved and 8 open orphan designations naming it.

  • Recruiting worldwide: 23
  • Trials authorized in Canada: 1
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 23 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 3

Phase 2 7

How its trials ended

112 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 23 whose ending is known, 30% met their primary endpoint, 9% missed it and 61% stopped early.

  • Completed, result not reported4338%
  • Ongoing3329%
  • Status unknown1312%
  • Stopped: other or unclear98%
  • Met its primary endpoint76%
  • Stopped: enrollment or feasibility33%
  • Missed its primary endpoint22%
  • Stopped: sponsor or business decision22%

Trials authorized in Canada

Newest first; search them all in Canada trials
AuthorizedTrialSponsorStatus
Mar 31, 2023A phase 1/2, multicenter, open-label study to evaluate the safety, tolerability, and preliminary efficacy of percutaneous injection of RP-008 followed by daily…RP-008 / Varenicline / Prednisone / Prednisolone sodium phosphateKriya TherapeuticsOngoing

FDA orphan designations

Approved first, then open designations, newest first
Nov 3, 2026BasimglurantTreatment of trigeminal neuralgiaNoema Pharma AGDesignated
May 22, 2026Trimeprazine tartrateTreatment of trigeminal neuralgiaUndaunted Bio, Inc.Designated
Jan 31, 2024A potent negative allosteric modulator (NAM) of human…Treatment of trigeminal neuralgiaShanghai SIMR Biotechnology Co., Ltd.Designated
Dec 17, 2015Carbon dioxideTreatment of trigeminal neuralgiaCapnia, Inc.Designated
Jul 24, 2013VixotrigineTreatment of trigeminal neuralgiaBiogen, Inc.Designated
Mar 16, 2012Dehydrated alcoholTreatment of trigeminal neuralgiaLuitpold Pharmaceuticals, Inc.Designated
Jan 6, 1998L-baclofenTreatment of trigeminal neuralgiaOsmotica Pharmaceutical Corp.Designated
Jul 13, 1990L-baclofenTreatment of trigeminal neuralgia.Fromm, Gerhard M.D.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.